A detailed history of Centennial Bank/Ar/ transactions in Viatris Inc stock. As of the latest transaction made, Centennial Bank/Ar/ holds 61 shares of VTRS stock, worth $756. This represents 0.0% of its overall portfolio holdings.

Number of Shares
61
Previous 689 91.15%
Holding current value
$756
Previous $7.32 Million 90.33%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024

SELL
$10.32 - $12.13 $6,480 - $7,617
-628 Reduced 91.15%
61 $708,000
Q2 2024

Aug 30, 2024

SELL
$10.05 - $12.02 $4,813 - $5,757
-479 Reduced 41.01%
689 $7.32 Million
Q4 2023

Aug 29, 2024

SELL
$8.77 - $10.85 $429 - $531
-49 Reduced 4.03%
1,168 $12.6 Million
Q3 2023

Aug 28, 2024

SELL
$9.59 - $11.35 $469 - $556
-49 Reduced 4.03%
1,168 $11.5 Million
Q4 2022

Aug 29, 2024

BUY
$8.72 - $11.56 $427 - $566
49 Added 4.2%
1,217 $13.5 Million
Q4 2022

Aug 26, 2024

BUY
$8.72 - $11.56 $10,612 - $14,068
1,217 New
1,217 $13.5 Million

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $15B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Centennial Bank/Ar/ Portfolio

Follow Centennial Bank/Ar/ and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Centennial Bank/Ar/, based on Form 13F filings with the SEC.

News

Stay updated on Centennial Bank/Ar/ with notifications on news.